Rheumatoid Arthritis
2,478
134
211
1,598
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
660 trials with published results (27%)
Research Maturity
1598 completed trials (64% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
8.2%
203 terminated out of 2478 trials
88.7%
+2.2% vs benchmark
24%
585 trials in Phase 3/4
41%
660 of 1598 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1598 completed trials
Clinical Trials (2478)
An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis
Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis
Discovering the Antecedents of Rheumatoid Arthritis Flare
Disulfiram in Rheumatoid Arthritis
Efficiency of a Tight Monitoring by a Nurse Practitioner of Rheumatoid Arthritis (RA) Patients in Remission
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
Immun4Cure Cohort of Autoimmune Diseases
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis
A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Effectiveness Evaluation of a Mobile Application for Rheumatoid Arthritis
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）
Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis
ROSA Knee Intraoperative Planning Flexibility Study
Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease